Anti-spike mucosal IgA protection against SARS-CoV-2 omicron infection
S Havervall, U Marking, J Svensson… - … England Journal of …, 2022 - Mass Medical Soc
New England Journal of Medicine, 2022•Mass Medical Soc
Anti-Spike Mucosal IgA Protection against SARS-CoV-2 Omicron Infection | New England Journal
of Medicine Skip to main content The New England Journal of Medicine homepage Advanced
Search SEARCH SPECIALTIES Cardiology Clinical Medicine Emergency Medicine
Endocrinology Gastroenterology Hematology/Oncology Infectious Disease Nephrology
Neurology/Neurosurgery Obstetrics/Gynecology Pediatrics Pulmonary/Critical Care View All
Specialties TOPICS AI in Medicine Climate Crisis and Health Coronavirus Fundamentals of Health …
of Medicine Skip to main content The New England Journal of Medicine homepage Advanced
Search SEARCH SPECIALTIES Cardiology Clinical Medicine Emergency Medicine
Endocrinology Gastroenterology Hematology/Oncology Infectious Disease Nephrology
Neurology/Neurosurgery Obstetrics/Gynecology Pediatrics Pulmonary/Critical Care View All
Specialties TOPICS AI in Medicine Climate Crisis and Health Coronavirus Fundamentals of Health …
Protection against Omicron by Mucosal IgA Antibodies
In this study, SARS-CoV-2 infection before vaccination was found to elicit mucosal IgA, which protects against infection. Vaccines inducing mucosal immunity may be important for preventing infection.
The New England Journal Of Medicine